tiprankstipranks
Trending News
More News >
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market

Travere Therapeutics (TVTX) Ratios

Compare
588 Followers

Travere Therapeutics Ratios

TVTX's free cash flow for Q4 2025 was $0.84. For the 2025 fiscal year, TVTX's free cash flow was decreased by $ and operating cash flow was $-0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.74 2.74 2.08 3.47 3.42
Quick Ratio
2.70 2.70 2.04 3.41 3.39
Cash Ratio
0.58 0.58 0.29 0.33 0.43
Solvency Ratio
0.02 0.02 -0.52 -0.12 -0.41
Operating Cash Flow Ratio
0.24 0.24 -1.18 -1.57 -1.31
Short-Term Operating Cash Flow Coverage
6.43 6.43 -3.46 0.00 0.00
Net Current Asset Value
$ -52.80M$ -52.80M$ -118.35M$ 28.67M$ -143.30M
Leverage Ratios
Debt-to-Assets Ratio
0.56 0.54 0.68 0.51 0.61
Debt-to-Equity Ratio
2.96 2.86 6.80 2.02 9.51
Debt-to-Capital Ratio
0.75 0.74 0.87 0.67 0.90
Long-Term Debt-to-Capital Ratio
0.74 0.74 0.84 0.65 0.90
Financial Leverage Ratio
5.27 5.27 10.06 3.93 15.70
Debt Service Coverage Ratio
1.28 1.28 -3.33 -28.80 -27.21
Interest Coverage Ratio
-5.84 -5.85 -28.96 -34.25 -29.04
Debt to Market Cap
0.13 0.10 0.28 0.57 0.28
Interest Debt Per Share
3.88 3.81 5.23 5.60 6.56
Net Debt to EBITDA
11.11 10.61 -1.29 -1.06 -1.15
Profitability Margins
Gross Profit Margin
94.20%85.51%96.68%92.12%95.96%
EBIT Margin
-7.85%-7.85%-132.66%-251.16%-292.47%
EBITDA Margin
4.53%4.53%-113.98%-224.63%-273.54%
Operating Profit Margin
-12.80%-12.80%-138.88%-267.24%-292.17%
Pretax Profit Margin
-10.04%-10.04%-137.45%-258.96%-302.54%
Net Profit Margin
-10.24%-10.24%-137.90%-76.70%-254.41%
Continuous Operations Profit Margin
-10.24%-10.24%-137.51%-259.11%-302.82%
Net Income Per EBT
102.01%102.01%100.32%29.62%84.09%
EBT Per EBIT
78.43%78.43%98.98%96.90%103.55%
Return on Assets (ROA)
-8.30%-8.30%-54.12%-14.12%-41.40%
Return on Equity (ROE)
-79.16%-43.77%-544.28%-55.47%-649.88%
Return on Capital Employed (ROCE)
-14.11%-14.11%-82.32%-63.52%-60.29%
Return on Invested Capital (ROIC)
-13.92%-13.92%-69.27%-63.02%-59.79%
Return on Tangible Assets
-10.23%-10.23%-65.60%-16.28%-48.39%
Earnings Yield
-2.06%-1.47%-23.40%-16.68%-20.77%
Efficiency Ratios
Receivables Turnover
6.03 6.12 8.60 6.86 6.58
Payables Turnover
1.15 2.87 0.33 0.27 0.26
Inventory Turnover
4.85 12.10 1.25 1.22 0.98
Fixed Asset Turnover
33.62 33.62 11.88 5.69 3.64
Asset Turnover
0.81 0.81 0.39 0.18 0.16
Working Capital Turnover Ratio
1.91 1.99 0.71 0.37 0.27
Cash Conversion Cycle
-182.02 -37.58 -774.56 -975.31 -998.78
Days of Sales Outstanding
60.57 59.60 42.45 53.23 55.51
Days of Inventory Outstanding
75.31 30.17 292.23 299.97 373.51
Days of Payables Outstanding
317.89 127.35 1.11K 1.33K 1.43K
Operating Cycle
135.88 89.77 334.67 353.19 429.01
Cash Flow Ratios
Operating Cash Flow Per Share
0.42 0.42 -3.01 -3.77 -2.92
Free Cash Flow Per Share
0.29 0.42 -4.29 -4.33 -3.37
CapEx Per Share
0.13 0.00 1.28 0.56 0.44
Free Cash Flow to Operating Cash Flow
0.69 1.00 1.43 1.15 1.15
Dividend Paid and CapEx Coverage Ratio
3.21 0.00 -2.35 -6.73 -6.57
Capital Expenditure Coverage Ratio
3.21 0.00 -2.35 -6.73 -6.57
Operating Cash Flow Coverage Ratio
0.11 0.11 -0.59 -0.69 -0.46
Operating Cash Flow to Sales Ratio
0.08 0.08 -1.02 -1.93 -1.70
Free Cash Flow Yield
1.04%1.11%-24.65%-48.17%-16.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-48.47 -67.82 -4.27 -5.99 -4.81
Price-to-Sales (P/S) Ratio
5.07 6.95 5.89 4.60 12.25
Price-to-Book (P/B) Ratio
21.22 29.69 23.26 3.32 31.29
Price-to-Free Cash Flow (P/FCF) Ratio
95.72 90.22 -4.06 -2.08 -6.25
Price-to-Operating Cash Flow Ratio
64.48 90.22 -5.79 -2.38 -7.20
Price-to-Earnings Growth (PEG) Ratio
-1.04 0.79 -0.02 0.09 -0.11
Price-to-Fair Value
21.22 29.69 23.26 3.32 31.29
Enterprise Value Multiple
123.11 164.03 -6.46 -3.11 -5.63
Enterprise Value
2.74B 3.64B 1.72B 1.01B 1.69B
EV to EBITDA
123.11 164.03 -6.46 -3.11 -5.63
EV to Sales
5.57 7.43 7.36 6.98 15.41
EV to Free Cash Flow
105.21 96.46 -5.07 -3.15 -7.86
EV to Operating Cash Flow
72.40 96.46 -7.23 -3.62 -9.05
Tangible Book Value Per Share
0.01 0.01 -0.57 1.30 -0.85
Shareholders’ Equity Per Share
1.27 1.29 0.75 2.70 0.67
Tax and Other Ratios
Effective Tax Rate
-0.02 -0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
5.43 5.50 2.96 1.96 1.72
Net Income Per Share
-0.56 -0.56 -4.08 -1.50 -4.37
Tax Burden
1.02 1.02 1.00 0.30 0.84
Interest Burden
1.28 1.28 1.04 1.03 1.03
Research & Development to Revenue
0.42 0.42 1.21 1.69 2.08
SG&A to Revenue
0.48 0.00 1.13 1.83 1.80
Stock-Based Compensation to Revenue
0.07 0.09 0.16 0.30 0.35
Income Quality
-0.75 -1.48 0.74 0.74 0.56
Currency in USD